KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $360.4 million.

  • Cme's Shares Outstanding (Diluted Average) rose 12.03% to $360.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $360.4 million, marking a year-over-year increase of 12.03%. This contributed to the annual value of $359.9 million for FY2024, which is 12.35% up from last year.
  • Latest data reveals that Cme reported Shares Outstanding (Diluted Average) of $360.4 million as of Q3 2025, which was up 12.03% from $360.4 million recorded in Q2 2025.
  • Cme's Shares Outstanding (Diluted Average)'s 5-year high stood at $360.4 million during Q3 2025, with a 5-year trough of $358.8 million in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $359.4 million (2023), whereas its average is $359.5 million.
  • In the last 5 years, Cme's Shares Outstanding (Diluted Average) grew by 3.7% in 2023 and then increased by 14.47% in 2024.
  • Quarter analysis of 5 years shows Cme's Shares Outstanding (Diluted Average) stood at $358.9 million in 2021, then rose by 0.07% to $359.2 million in 2022, then increased by 0.09% to $359.5 million in 2023, then rose by 0.12% to $359.9 million in 2024, then rose by 0.13% to $360.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $360.4 million for Q3 2025, versus $360.4 million for Q2 2025 and $360.2 million for Q1 2025.